These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9735143)

  • 21. Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.
    Guinzberg R; Cortés D; Díaz-Cruz A; Riveros-Rosas H; Villalobos-Molina R; Piña E
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E940-51. PubMed ID: 16352677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes.
    Zibrova D; Grempler R; Streicher R; Kauschke SG
    Biochem J; 2008 Jun; 412(2):359-66. PubMed ID: 18298402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specifically.
    Ikezawa Y; Yamatani K; Ohnuma H; Igarashi M; Daimon M; Manaka H; Sasaki H
    J Lab Clin Med; 2001 Dec; 138(6):387-92. PubMed ID: 11753285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose regulated production of human insulin in rat hepatocytes.
    Thulé PM; Liu J; Phillips LS
    Gene Ther; 2000 Feb; 7(3):205-14. PubMed ID: 10694797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of glycogen synthesis by increased lipid availability is associated with subcellular redistribution of glycogen synthase.
    Taylor AJ; Ye JM; Schmitz-Peiffer C
    J Endocrinol; 2006 Jan; 188(1):11-23. PubMed ID: 16394171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt.
    Weigert C; Hennige AM; Brodbeck K; Häring HU; Schleicher ED
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E251-7. PubMed ID: 15755769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis.
    Buettner R; Ottinger I; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E828-33. PubMed ID: 14722026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.
    Li ZG; Qiang X; Sima AA; Grunberger G
    Biochem Biophys Res Commun; 2001 Jan; 280(3):615-9. PubMed ID: 11162564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
    Frick W; Bauer A; Bauer J; Wied S; Müller G
    Biochemistry; 1998 Sep; 37(38):13421-36. PubMed ID: 9748349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine.
    Rajasekar P; Anuradha CV
    Life Sci; 2007 Mar; 80(13):1176-83. PubMed ID: 17239403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
    Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
    Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential insulin degradation in cultured fetal hepatocytes in relation to chloroquine-dependent events.
    Zachayus JL; Khan S; Plas C
    Am J Physiol; 1996 Sep; 271(3 Pt 1):E417-25. PubMed ID: 8843733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative description of the insulin-induced ultrastructural changes in newborn rat hepatocytes.
    Maintas DB; Kotoulas OB; Kotoulas AO
    Histol Histopathol; 1993 Apr; 8(2):235-42. PubMed ID: 8490249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A microassay for measuring glycogen in 96-well-cultured cells.
    Gómez-Lechón MJ; Ponsoda X; Castell JV
    Anal Biochem; 1996 May; 236(2):296-301. PubMed ID: 8660508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes.
    Duckworth WC; Hamel FG; Liepnieks JJ; Peavy DE; Ryan MP; Hermodson MA; Frank BH
    Biochem Biophys Res Commun; 1987 Sep; 147(2):615-21. PubMed ID: 3307783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an insulin fragment produced by an insulin degrading enzyme, neutral thiopeptidase.
    Varandani PT; Shroyer LA
    Mol Cell Endocrinol; 1987 Apr; 50(3):171-5. PubMed ID: 3552782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The determination of the biological activity of insulin by a radioreceptor method].
    Dimitrova E; Sirakov L
    Eksp Med Morfol; 1993; 31(3-4):72-86. PubMed ID: 7805622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of modified insulin B21-B26 fragments on glycogenesis and on insulin-receptor complex fate in cultured fetal hepatocytes.
    Menuelle P; Plas C; Taketomi S
    Mol Cell Endocrinol; 1989 Oct; 66(2):143-51. PubMed ID: 2693157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
    Duckworth WC; Hamel FG; Liepnieks J; Frank BH; Yagil C; Rabkin R
    Endocrinology; 1988 Dec; 123(6):2701-8. PubMed ID: 3058457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification of a major product of the degradation of insulin by 'insulin proteinase' (EC 3.4.22.11).
    Muir A; Offord RE; Davies JG
    Biochem J; 1986 Aug; 237(3):631-7. PubMed ID: 3541902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.